Complement C5a inhibition moderates lipid metabolism and reduces tubulointerstitial fibrosis in diabetic nephropathy. (2018)

First Author: Yiu WH

Attributed to: MRC Centre for Transplantation funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/ndt/gfx336

PubMed Identifier: 29294056

Publication URI: http://europepmc.org/abstract/MED/29294056

Type: Journal Article/Review

Volume: 33

Parent Publication: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Issue: 8

ISSN: 0931-0509